Insider Trading activities of Haemonetics Corp insiders. , Part 4

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Haemonetics Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Haemonetics Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Haemonetics Corp since 2005. The reporting company's ticker symbol is HAE. The reporting company's CIK number is 313143.
The total value of stock buying since 2005 is $9,297,802.
The total value of stock sales since 2005 is $165,120,821.
The total value of stock option exercises since 2005 is $80,860,127.


 1   2   3   4 

Table 2. Detailed insider stock purchases, sales, and option exercises of Haemonetics Corp insiders (HAE) , Part 4
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-10-15 Nutter Brad (President & CEO) Sale 50,000 56.33 2,816,400
2008-10-15 Nutter Brad (President & CEO) Option Ex 50,000 21.91 1,095,500
2008-09-15 Nutter Brad (President & CEO) Sale 50,000 63.75 3,187,600
2008-09-15 Nutter Brad (President & CEO) Option Ex 50,000 21.91 1,095,500
2008-09-09 Ebbeling Robert B (Vice President, Operations) Sale 21,652 65.00 1,407,380
2008-09-09 Ebbeling Robert B (Vice President, Operations) Option Ex 21,652 19.39 419,832
2008-09-08 Ebbeling Robert B (Vice President, Operations) Sale 21,646 65.00 1,406,990
2008-09-08 Ebbeling Robert B (Vice President, Operations) Option Ex 21,646 19.16 414,650
2008-08-15 Nutter Brad (President & CEO) Sale 50,000 61.05 3,052,750
2008-08-15 Nutter Brad (President & CEO) Option Ex 50,000 21.91 1,095,500
2008-08-08 Corlin Remi (President, Asia) Sale 18,500 63.17 1,168,682
2008-08-08 Corlin Remi (President, Asia) Option Ex 18,500 29.24 540,903
2008-07-22 Nutter Brad (President & CEO) Sale 50,000 55.00 2,750,000
2008-07-22 Nutter Brad (President & CEO) Option Ex 50,000 21.91 1,095,500
2008-06-30 Pare Anthony (Other) Sale 500 57.40 28,700
2008-06-30 Pare Anthony (Other) Option Ex 500 26.11 13,052
2008-06-16 Nutter Brad (President & CEO) Sale 50,000 57.13 2,856,300
2008-06-16 Nutter Brad (President & CEO) Option Ex 50,000 21.91 1,095,500
2008-05-16 Concannon Brian (Chief Operating Officer) Sale 775 55.44 42,966
2008-05-16 Nutter Brad (President & CEO) Sale 50,000 55.05 2,752,600
2008-05-16 Nutter Brad (President & CEO) Option Ex 50,000 21.91 1,095,500
2008-05-05 Granadillo Pedro P (Director) Buy 1,800 53.59 96,462
2008-05-01 Pare Anthony (Other) Buy 231 44.35 10,245
2008-05-01 O'shaughnessy James (Other) Buy 440 44.35 19,515
2008-05-01 Conneely Jan (VP & GM, Arryx, Inc.) Buy 304 44.35 13,483
2008-05-01 Hattori Keiko (President, Haemonetics Japan) Buy 126 44.35 5,588
2008-05-01 Granville William (VP, Manufacturing) Buy 411 44.35 18,229
2008-05-01 Popovsky Mark A (VP, Corporate Medical Director) Buy 246 44.35 10,910
2008-05-01 Lindop Christopher J (VP, Finance & CFO) Buy 260 44.35 11,531
2008-05-01 Allen Peter M (President, Donor Division) Buy 297 44.35 13,172
2008-05-01 Concannon Brian (President, Patient Division) Buy 479 44.35 21,245
2008-05-01 Lopez Alicia R (VP, General Counsel) Buy 328 44.35 14,547
2008-05-01 Swenson Stephen (VP & General Mgr, Global Plasm) Buy 238 44.35 10,556
2008-05-01 Ebbeling Robert B (Vice President, Operations) Buy 479 44.35 21,245
2008-05-01 Hanlon Susan M (VP, Planning and Control) Buy 138 44.35 6,120
2008-05-01 Beucler Mark (Other) Buy 422 44.35 18,716
2008-04-21 Pare Anthony (Other) Sale 500 55.98 27,990
2008-04-21 Pare Anthony (Other) Option Ex 500 26.11 13,052
2008-03-13 Swenson Stephen (VP & General Mgr, Global Plasm) Sale 400 58.87 23,549
2008-03-13 Swenson Stephen (VP & General Mgr, Global Plasm) Option Ex 400 26.11 10,442
2008-03-12 Swenson Stephen (VP & General Mgr, Global Plasm) Sale 223 58.43 13,029
2008-02-28 Lopez Alicia R (VP, General Counsel) Sale 9,500 58.70 557,669
2008-02-28 Lopez Alicia R (VP, General Counsel) Option Ex 9,500 17.62 167,437
2008-01-02 Popovsky Mark A (VP, Corporate Medical Director) Sale 10,000 61.98 619,800
2008-01-02 Popovsky Mark A (VP, Corporate Medical Director) Option Ex 10,000 28.88 288,820
2007-11-28 Lawlor Thomas (President, Patient Division) Sale 12,500 57.55 719,437
2007-11-28 Lawlor Thomas (President, Patient Division) Option Ex 12,500 47.51 593,875
2007-11-06 Allen Peter M (President, Donor Division) Sale 6,350 57.44 364,731
2007-11-06 Allen Peter M (President, Donor Division) Option Ex 6,350 21.46 136,271
2007-11-01 Popovsky Mark A (VP, Corporate Medical Director) Buy 253 40.66 10,287
2007-11-01 Lindop Christopher J (VP, Finance & CFO) Buy 284 40.66 11,548
2007-11-01 Allen Peter M (President, Donor Division) Buy 197 40.66 8,010
2007-11-01 Lopez Alicia R (VP, General Counsel) Buy 182 40.66 7,400
2007-11-01 Ebbeling Robert B (Vice President, Operations) Buy 144 40.66 5,855
2007-11-01 Hanlon Susan M (VP, Planning and Control) Buy 139 40.66 5,652
2007-07-02 Popovsky Mark A (VP, Corporate Medical Director) Sale 7,000 52.79 369,502
2007-07-02 Popovsky Mark A (VP, Corporate Medical Director) Option Ex 7,000 22.72 159,026
2007-06-14 Sakai Ryoji (President, Japan) Sale 8,000 51.00 408,000
2007-06-14 Sakai Ryoji (President, Japan) Option Ex 8,000 31.66 253,280
2007-05-04 Still William Roche (VP & Gen Mrg, Therapeutics Bus) Sale 10,000 50.07 500,730
2007-05-04 Still William Roche (VP & Gen Mrg, Therapeutics Bus) Option Ex 10,000 24.23 242,350
2007-05-01 Popovsky Mark A (VP, Corporate Medical Director) Buy 282 38.63 10,894
2007-05-01 Still William Roche (VP & Gen Mrg, Therapeutics Bus) Buy 344 38.63 13,289
2007-05-01 Allen Peter M (President, Donor Division) Buy 341 38.63 13,173
2007-05-01 Forish Joseph J (VP, Human Resources) Buy 1,100 38.63 42,494
2007-05-01 Lopez Alicia R (VP, General Counsel) Buy 357 38.63 13,791
2007-05-01 Lopez Alicia R (VP, General Counsel) Sale 452 47.84 21,624
2007-05-01 Ebbeling Robert B (Vice President, Operations) Buy 397 38.63 15,336
2007-05-01 Hanlon Susan M (VP, Planning and Control) Buy 146 38.63 5,640
2007-04-25 Popovsky Mark A (VP, Corporate Medical Director) Sale 7,000 48.00 336,000
2007-04-25 Popovsky Mark A (VP, Corporate Medical Director) Option Ex 7,000 22.72 159,026
2007-02-28 Lopez Alicia R (VP, General Counsel) Sale 5,883 44.75 263,264
2007-02-28 Lopez Alicia R (VP, General Counsel) Option Ex 5,883 17.44 102,581
2007-02-13 Ebbeling Robert B (Vice President, Operations) Sale 12,300 47.02 578,333
2007-02-13 Ebbeling Robert B (Vice President, Operations) Option Ex 12,300 17.00 209,100
2007-02-02 Popovsky Mark A (VP, Corporate Medical Director) Sale 10,000 47.79 477,900
2007-02-02 Popovsky Mark A (VP, Corporate Medical Director) Option Ex 10,000 22.72 227,180
2007-02-02 Still William Roche (VP & Gen Mrg, Therapeutics Bus) Sale 10,000 47.78 477,840
2007-02-02 Still William Roche (VP & Gen Mrg, Therapeutics Bus) Option Ex 10,000 24.23 242,350
2006-11-01 Popovsky Mark A (VP, Corporate Medical Director) Buy 228 38.76 8,837
2006-11-01 Still William Roche (VP & Gen Mrg, Therapeutics Bus) Buy 180 38.76 6,976
2006-11-01 Allen Peter M (President, Donor Division) Buy 181 38.76 7,015
2006-11-01 Eckert Ulrich (President, Europe & Latin Am) Buy 159 38.76 6,162
2006-11-01 Forish Joseph J (VP, Human Resources) Buy 460 38.76 17,829
2006-11-01 Lopez Alicia R (VP, General Counsel) Buy 119 38.76 4,612
2006-11-01 Lopez Alicia R (VP, General Counsel) Sale 400 45.77 18,306
2006-11-01 Ryan Ronald J (VP and CFO) Buy 173 38.76 6,705
2006-11-01 Ebbeling Robert B (Vice President, Operations) Buy 184 38.76 7,131
2006-11-01 Hanlon Susan M (VP, Planning and Control) Buy 140 38.76 5,426
2006-09-07 Ryan Ronald J (VP and CFO) Sale 59,694 45.48 2,715,121
2006-09-07 Ryan Ronald J (VP and CFO) Option Ex 59,694 28.45 1,698,592
2006-08-22 Corlin Remi (President, Asia) Sale 2,500 47.39 118,475
2006-08-22 Corlin Remi (President, Asia) Option Ex 2,500 15.88 39,687
2006-08-10 Ryan Ronald J (VP and CFO) Sale 93,016 45.00 4,185,720
2006-08-10 Ryan Ronald J (VP and CFO) Option Ex 93,016 15.88 1,476,628
2006-08-02 Ryan Ronald J (VP and CFO) Sale 50,000 45.00 2,250,000
2006-08-02 Ryan Ronald J (VP and CFO) Option Ex 50,000 17.73 886,700
2006-08-02 Gelbman Ronald G (Director) Buy 4,442 44.99 199,867
2006-07-03 Lopez Alicia R (VP, General Counsel) Sale 400 46.70 18,682
2006-06-27 Ryan Ronald J (VP and CFO) Sale 50,000 47.21 2,360,450
2006-06-27 Ryan Ronald J (VP and CFO) Option Ex 50,000 16.06 803,100
2006-06-23 Eckert Ulrich (President, Europe & Latin Am) Sale 5,000 49.45 247,250
2006-06-23 Eckert Ulrich (President, Europe & Latin Am) Option Ex 5,000 15.88 79,375
2006-06-22 Eckert Ulrich (President, Europe & Latin Am) Sale 8,000 48.07 384,560
2006-06-22 Eckert Ulrich (President, Europe & Latin Am) Option Ex 8,000 16.08 128,624
2006-06-12 Eckert Ulrich (President, Europe & Latin Am) Sale 1,000 46.94 46,940
2006-06-01 Best Lawrence C (Director) Buy 100,000 46.55 4,654,900
2006-05-01 Popovsky Mark A (Vp, Corporate Medical Director) Buy 258 41.52 10,712
2006-05-01 Still William Roche (VP & Gen Mrg, Therapeutics Bus) Buy 311 41.52 12,913
2006-05-01 Allen Peter M (President, Donor Division) Buy 310 41.52 12,871
2006-05-01 Concannon Brian (President, Patient Division) Buy 511 41.52 21,217
2006-05-01 Lopez Alicia R (VP, General Counsel) Buy 379 41.52 15,736
2006-05-01 Ryan Ronald J (VP and CFO) Buy 158 41.52 6,560
2006-05-01 Ebbeling Robert B (Vice President, Operations) Buy 307 41.52 12,747
2006-05-01 Hanlon Susan M (VP, Planning and Control) Buy 113 41.52 4,691
2006-03-24 Lopez Alicia R (VP, General Counsel) Option Ex 24,200 18.00 435,600
2006-03-21 Eckert Ulrich (President, Europe & Latin Am) Option Ex 4,000 18.00 72,000
2006-02-02 Popovsky Mark A (Vp, Corporate Medica) Sale 7,000 50.20 351,400
2006-02-02 Popovsky Mark A (Vp, Corporate Medica) Option Ex 7,000 22.72 159,033
2006-02-02 Still William Roche (Bus. Dev.) Buy 2,110 49.75 104,972
2005-11-22 Foote Susan Bartlett (Director) Buy 2,000 49.25 98,492
2005-11-02 Granadillo Pedro P (Director) Buy 3,000 48.86 146,589
2005-11-01 Allen Peter M (President, Donor Div) Buy 203 35.88 7,283
2005-09-02 Granadillo Pedro P (Director) Buy 1,000 44.71 44,710
2005-05-02 Popovsky Mark A (Vp, Corporate Medica) Buy 441 27.20 11,995
2005-05-02 Still William Roche (Bus. Dev.) Buy 422 .20 84
2005-05-02 Allen Peter M (President, Donor Div) Buy 262 27.20 7,126
2005-05-02 Concannon Brian (President, Patient D) Buy 800 27.20 21,760
2005-05-02 Lopez Alicia R (VP, Administ) Buy 472 27.20 12,838
2005-05-02 Sakurada Yutaka (Asia) Buy 63 27.20 1,713
2005-05-02 Ryan Ronald J (CFO) Buy 236 27.20 6,419
2005-05-02 Ebbeling Robert B (Vice President, Oper) Buy 428 27.20 11,641
2005-05-02 Hanlon Susan M (V.P Planning and Con) Buy 166 27.20 4,515
2005-04-15 Lopez Alicia R (VP, Administ) Sale 400 77.00 30,800
2004-04-15 Lopez Alicia R (VP, Administ) Sale 400 29.55 11,820
 1   2   3   4 

Insider trading activities including stock purchases, stock sales, and option exercises of HAE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Haemonetics Corp (symbol HAE, CIK number 313143) see the Securities and Exchange Commission (SEC) website.